What This Means for Patients If you were previously on a compounded medication, transitioning to an FDA-approved GLP-1 may provide: Greater dosing precision Clearer insurance pathways Established safety profiles Long-term data Our goal is sustainable, medically guided weight loss, not short-term trends
Medical literature and post-marketing data have raised concerns about gastrointestinal complications, particularly when these drugs are used long term
Women with PCOS and excess weight can experience improved fertility The most encouraging data are in women with PMOS (formerly PCOS) and higher BMI
For the most accurate values, you will be required to fast for ten hours prior to your scheduled blood draw
A detailed gastrointestinal history is important for identifying patients at higher risk of GLP-1-related side effects
RCT, randomized controlled trial